跳至主要内容
临床试验/NCT00924118
NCT00924118已完成2 期

A Safety and Efficacy Evaluation of Sodium Nitrite Injection for the Prevention of Ischemia-Reperfusion Injury Associated With Acute Myocardial Infarction.

Johns Hopkins University3 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2009年7月最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
30
试验地点
3
主要终点
Ischemia Area at Risk as Determined by Paired Single-photon Computed Tomography Studies With Technetium Tc99m Sestamibi.

研究概览

简要总结

The purpose of this study is to determine whether the intravenous infusion of sodium nitrite safely prevents ischemia-reperfusion injury in subjects with acute myocardial infarction resulting in improved left ventricular function.

详细描述

Despite reperfusion therapies, significant myocardial injury continues to occur from ischemic-reperfusion injury. Studies in animal models of acute myocardial infarction suggest that an infusion of sodium nitrite, which is nonenzymatically converted to nitric oxide in the setting of ischemia, significantly reduces ischemia-reperfusion injury resulting in smaller infarcts and improved left ventricular function. The objectives of this phase 2 trial are to determine the tolerability and safety of a 48-hour infusion of sodium nitrite in patients with an acute ST-segment elevation myocardial infarction receiving percutaneous coronary intervention. The efficacy of a 48-hour infusion of sodium nitrite will be determined by noninvasive imaging to determine infarct size and left ventricular function.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Acute ST segment elevation myocardial infarction
  • Eligible for percutaneous coronary intervention

排除标准

  • Cardiogenic shock
  • Cardiac arrest
  • Prior infarct in the infarct related artery
  • Hemoglobinopathy, Glucose-6 Phosphate Dehydrogenase (G6PD) deficiency

研究组 & 干预措施

Sodium Nitrite

Experimental

Dose escalation of sodium nitrite.

干预措施: Sodium Nitrite (Drug)

结局指标

主要结局

Ischemia Area at Risk as Determined by Paired Single-photon Computed Tomography Studies With Technetium Tc99m Sestamibi.

时间窗: 4-5 days from enrollment

Measured as percentage of left ventricle

次要结局

  • Left Ventricular Infarct Size(4-5 days following enrollment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验